Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data - Concepedia

Concepedia

Publication | Open Access

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data

DOI Full Paper Access

20

Citations

21

References

2024

Year

Alexander Olkus, Aurelie Tomczak, Anne Berger, Conrad Rauber, Philip Puchas, Cyrill Wehling, Thomas Longerich, Arianeb Mehrabi, De‐Hua Chang, Jakob Liermann,

Targeted Oncology

Abstract

The treatment of advanced patients with BTC with durvalumab and gem/cis, even beyond the inclusion criteria of the TOPAZ-1 trial, shows promising safety.

References

	Year	Citations

Page 1